Allen Lutz, an analyst from Bank of America Securities, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target remains the same with $63.00. Discover ...

"Corner drugstore" may be an apt phrase, because you can hardly turn a corner without running into a CVS, Rite Aid ... chains scored no higher in our Ratings of walk-in drugstores than big ...

CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island. Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to ...

Revenue rose 6.3% to $95.43 billion, topping analysts’ estimates of $92.72 billion, according to a FactSet survey ... older.

"We would be buyers of CVS and UNH," Piper analyst Jessica Tassan wrote, adding that their 2025-Star Ratings profiles, which result in annual bonus payments from the CMS for healthcare plans with ...

Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, has posted a ...

CVS) shares, reiterating an Overweight rating and a price target of $64.00. Currently trading at $51.57, InvestingPro analysis indicates CVS is undervalued, with the stock showing a significant 12 ...